US Patent Issued to ARRAY BIOPHARMA on July 8 for "Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases" (Indiana Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,571, issued on July 8, was assigned to ARRAY BIOPHARMA INC. (Boulder, Colo.).

"Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases" was invented by James F. Blake (Indianapolis), Li Ren (Indianapolis), David A. Moreno (Indianapolis) and Shane M. Walls (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are 7-((3,5-dimethoxyphenyl)amino)quinoxaline derivatives of the general Formula I; and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which X2 is N and Ring A, Ring B, Ring C, X1, X3, R1, L, and W have the meanings given in the specification, which are inhibitors of FGFR1, FGFR...